Cerebrovascular Disorders. Cerebrovascular Diseases . Cerebrovascular Insufficiency . Cerebrovascular Occlusion . Brain Vascular Disorder . Cerebrovascular Disease . Cerebrovascular Disorder . Cerebrovascular Insufficiencies . Cerebrovascular Occlusions . Disease, Cerebrovascular . Diseases, Cerebrovascular . Insufficiencies, Cerebrovascular . Insufficiency, Cerebrovascular . Intracranial Vascular Disease . Intracranial Vascular Diseases . Intracranial Vascular Disorder . Occlusion, Cerebrovascular . Occlusions, Cerebrovascular . Vascular Disease, Intracranial . Vascular Disorder, Brain . Vascular Disorder, Intracranial . Vascular Disorders, Brain . Vascular Disorders, Intracranial . Brain Vascular Disorders . Intracranial Vascular Disorders . Vascular Diseases, Intracranial . A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. . 0.70
Dipyridamole. Antistenocardin . Apo-Dipyridamole . Cerebrovase . Cléridium . Curantil . Curantyl . Dipyramidole . Kurantil . Miosen . Novo-Dipiradol . Persantin . Persantine . Apo Dipyridamole . Novo Dipiradol . A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) . 0.69